-

OSU Wexner Medical Center, Battelle Open Door to Using Neurotechnology at Home

COLUMBUS, Ohio--(BUSINESS WIRE)--The Ohio State University Wexner Medical Center has secured $800,000 in grants to develop with Battelle the NeuroLife interface technology for home use. This breakthrough technology will allow people with spinal cord injuries to regain immediate, impactful hand movements as well as connect to the “internet of things” that they might want to control in their home.

One grant, from the Ohio Third Frontier, will advance Battelle’s NeuroLife functional electrical stimulation system, a wearable, form-fitting neural interface garment that can reanimate the muscles of the forearm to improve hand function in people living with spinal cord injuries. By adding a universal neural interface, the system will allow participants to seamlessly control hand grip and other movements via a multitude of control signals, such as a smart phone, tablet, sip-and-puff or button switch.

This research furthers the medical breakthrough first pioneered by the Ohio State Wexner Medical Center and Battelle in 2014 when a paralyzed man was able to use his thoughts and this neural interface technology to move his fingers for the first time in a lab on the university campus.

“We’ll pursue research that translates our advances to daily use so that we can create the biggest impact for people,” said Dr. Marcie Bockbrader, a physician researcher at the Wexner Medical Center who will serve as the principal investigator for both studies and who has been closely involved with NeuroLife since its inception. “The goal is to create real, consumer-grade devices—not just lab demos—so that individuals living with spinal cord injuries can benefit and live a better quality of life.”

The second grant will transform Battelle’s NeuroLife brain-computer interface laboratory system into a sleek, portable system that is robust and easy to use at home. Supported by the Craig H. Neilsen Foundation, Battelle will miniaturize its stimulation hub and algorithms, and adapt its system for mobile use in conjunction with Blackrock Microsystems portable version of its human brain interface system.

“We envision people using their brain to directly control any computer or device in their homes with this technology,” said Justin Sanchez, tech fellow at Battelle and formerly director of DARPA’s Biological Technologies Office. “It’s not some far-off dream of the future; we’re actually building the infrastructure to do it today, and we’re using it to help a person who is living with paralysis.”

Battelle is rapidly expanding its neuro-technological capabilities. In 2014, the NeuroLife program reanimated the paralyzed hand of a quadriplegic man. Now, the team is poised for more dramatic success as it develops new approaches to treat spinal cord injuries, stroke and other movement disorders; bio-electronic medicine; and related non-medical neuro applications such as athletics and gaming.

About The Ohio State University Wexner Medical Center

One of the nation’s leading academic health centers, The Ohio State University Wexner Medical Center in Columbus, Ohio, offers health care services in virtually every specialty and subspecialty in medicine. Thousands of patients come to the medical center each month for treatments and services they can’t find anywhere else. Providing access to health care information is central to the medical center’s research, education and patient care mission. The Ohio State Wexner Medical Center is dedicated to improving health in Ohio and across the world through innovation in research, education and patient care. For more information, visit www.wexnermedical.osu.edu.

About Battelle

Every day, the people of Battelle apply science and technology to solving what matters most. At major technology centers and national laboratories around the world, Battelle conducts research and development, designs and manufactures products, and delivers critical services for government and commercial customers. Headquartered in Columbus, Ohio since its founding in 1929, Battelle serves the national security, health and life sciences, and energy and environmental industries. For more information, visit www.battelle.org.

Media Contacts

For more information from The Ohio State University Wexner Medical Center contact Eileen Scahill at (614) 293-3737 or Eileen.Scahill@osumc.edu.

For more information from Battelle contact Katy Delaney at (614) 424-7208 or delaneyk@battelle.org or T.R. Massey at (614) 424-5544 or masseytr@battelle.org.

Contacts

The Ohio State University Wexner Medical Center
Eileen Scahill, (614) 293-3737
Eileen.Scahill@osumc.edu

Battelle
Katy Delaney, (614) 424-7208
delaneyk@battelle.org
or
T.R. Massey at (614) 424-5544
masseytr@battelle.org

Battelle


Release Versions

Contacts

The Ohio State University Wexner Medical Center
Eileen Scahill, (614) 293-3737
Eileen.Scahill@osumc.edu

Battelle
Katy Delaney, (614) 424-7208
delaneyk@battelle.org
or
T.R. Massey at (614) 424-5544
masseytr@battelle.org

More News From Battelle

Battelle Extends Longstanding CDC Partnership with New Public Health Data and Mission Support Awards

COLUMBUS, Ohio--(BUSINESS WIRE)--Battelle today announced two significant awards from the Centers for Disease Control and Prevention (CDC), reinforcing the organization's longstanding partnership in advancing public health through data, analytics, science, and mission support services. Battelle was awarded a five-year, $12.3 million contract to provide information systems and technical data support for CDC's National Environmental Public Health (NEPH) Tracking Network, a critical resource that...

Battelle, CMC Pharmaceuticals Advance Medical Countermeasure Program for U.S. Department of War

COLUMBUS, Ohio--(BUSINESS WIRE)--Battelle and CMC Pharmaceuticals are advancing work with the United States Department of War to develop improved medical countermeasures intended to protect American warfighters from nerve agent threats. The five-year, $40 million Acetylcholinesterase (AChE) Reactivator Development and Approval Pipeline (ARDAP) Prototype Program was awarded through the Defense Threat Reduction Agency, Joint Science and Technology Office (DTRA-JSTO). The program is focused on adv...

Battelle Awarded Contract to Enhance Airbase Resilience

COLUMBUS, Ohio--(BUSINESS WIRE)--Battelle has been awarded a Defense Technical Information Center (DTIC) Information Analysis Center Multiple Award Contract (IAC MAC) Research, Development, Test and Evaluation (RDT&E) contract. The work will cover Operational Airbase Infrastructure Emerging Capabilities and Prototyping for the U.S. Air Force Civil Engineer Center (AFCEC) Capability Requirements Branch (CXAR). The award includes a $51.6 million base period, with a total potential value of $1...
Back to Newsroom